Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
34.47
-0.86 (-2.43%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Indivior Pharmaceuticals Employees
As of December 31, 2025, Indivior Pharmaceuticals had 838 total employees, including 827 full-time and 11 part-time employees. The number of employees decreased by 213 or 20.27% compared to the previous year. That makes Indivior Pharmaceuticals the 16,153rd largest employer in the world and 2,310th in the United States.
Employees
838
Change (1Y)
-213
Growth (1Y)
-20.27%
Revenue / Employee
$1,588,305
Profits / Employee
$424,821
Market Cap
4.07B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 838 | -213 | -20.27% | 827 | 11 |
| Jun 30, 2025 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Sep 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Jun 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Mar 31, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Sep 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Jun 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Mar 31, 2023 | 1,000 | 200 | 25.00% | 1,000 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Sep 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Jun 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Mar 31, 2022 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Sep 30, 2021 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| HUTCHMED (China) | 1,790 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| Kiniksa Pharmaceuticals International, | 366 |
INDV News
- 3 days ago - Huron to replace Supernus in S&P 600 at open on November 2 - TheFly
- 6 days ago - Indivior to Report Third Quarter 2026 Financial Results - GlobeNewsWire
- 10 days ago - Indivior Pharmaceuticals Transcript: EGM 2026 - Transcripts
- 5 weeks ago - Indivior declares $8.13 per share special cash dividend - TheFly
- 5 weeks ago - Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend - GlobeNewsWire
- 2 months ago - Indivior price target lowered to $43 from $46 at Barclays - TheFly
- 2 months ago - Indivior price target raised to $53 from $50 at Craig-Hallum - TheFly
- 2 months ago - Indivior Pharmaceuticals Slides: Corporate presentation - Filings